Tharimmune, Inc. - Common Stock (THAR) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2024 to Q3 2025

Type / Class
Equity / Common Stock
Symbol
THAR on Nasdaq
Shares outstanding
6,774,306
Price per share
$2.53
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
805,153
Total reported value
$2,286,635
% of total 13F portfolios
0%
Share change
+703,027
Value change
+$2,019,147
Number of holders
12
Price from insider filings
$2.53
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Tharimmune, Inc. - Common Stock (THAR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 9.8% $2,004,924 663,882 BlackRock, Inc. 30 Sep 2025

As of 30 Sep 2025, 12 institutional investors reported holding 805,153 shares of Tharimmune, Inc. - Common Stock (THAR). This represents 12% of the company’s total 6,774,306 outstanding shares.

Top 16 Institutional Shareholders

The largest institutional shareholders of Tharimmune, Inc. - Common Stock (THAR) together control 12% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 9.8% 663,882 0% $1,885,425
VANGUARD GROUP INC 0.68% 46,332 0% $131,583
GEODE CAPITAL MANAGEMENT, LLC 0.41% 27,932 +82% 0% $79,326
FRANKLIN RESOURCES INC 0.37% 25,000 -44% 0% $71,000
STATE STREET CORP 0.26% 17,521 0% $49,760
Drucker Wealth 3.0, LLC 0.15% 10,135 0.01% $28,783
CITIGROUP INC 0.15% 9,928 0% $28,196
PNC Financial Services Group, Inc. 0.03% 2,000 0% $5,680
SBI Securities Co., Ltd. 0.02% 1,525 -0.2% 0% $4,331
UBS Group AG 0.01% 833 -94% 0% $2,366
BANK OF AMERICA CORP /DE/ 0% 35 +46% 0% $99
Crewe Advisors LLC 0% 30 0% $86
XTX Topco Ltd 0% 0 -100% $0
Stone House Investment Management, LLC 0% 0 -100% $0
Tower Research Capital LLC (TRC) 0% 0 -100% $0
BRAVE ASSET MANAGEMENT INC 0% 0 -100% $0

Institutional Holders of Tharimmune, Inc. - Common Stock (THAR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 805,153 $2,286,635 +$2,019,147 $2.84 12
2025 Q2 102,126 $198,860 +$66,582 $1.94 9
2025 Q1 68,104 $92,621 -$170,640 $1.36 6
2024 Q4 149,093 $303,606 +$252,991 $2.03 10
2024 Q3 24,257 $60,157 +$39,400 $2.46 4
2024 Q2 6,181 $21,819 +$21,819 $3.53 4